A 24-hr treatment of V79 Chinese hamster lung fibroblasts with 12.4 ,uM cholesterol 5a,6a-epoxide induced 8-azaguanine-resistant mutants at frequencies 4.6-to 11.8-fold higher than the spontaneous mutation rate. We show that cholesterol epoxide, which is produced by in vivo cholesterol oxidation, is a weak direct-acting mutagen. Cholesterol epoxide was found to be accumulated by cells and transformed to cholestane-3.8,5x,6.8-triol, which was more toxic and a more potent inhibitor of DNA synthesis than the epoxide but, at concentrations less than 17.8 ,.M, was not significantly mutagenic. Consideration of the rates of cholesterol epoxide conversion to cholestane triol shows that this conversion can result in abolition of the mutagenicity of the epoxide. Conditions under which conversion of the epoxide to the triol is low, as in the case of low epoxide hydrolase activity, favor mutagenicity whereas rapid conversion to triol favors cytotoxicity.
Cholesterol 5a,6a-epoxide, a recognized oxidation product of cholesterol (Chol) (1) (2) (3) (4) , may also be a metabolic intermediate in bile acid biosynthesis (2, 5) and has been found to accumulate in such cases as hypercholesterolemia in humans (6) . The enzymatic oxidation of Chol is coupled with hydration reactions that form cholestane-3f3,5a,6f3-triol (7) .
(Throughout this paper, the terms Chol epoxide and cholestane triol will refer to the Sa,6a and 3,1,5a,613 isomers, respectively, unless otherwise specified.) Since Chol epoxide possesses an electrophilic oxirane group, it could be expected to be genotoxic and carcinogenic (8, 9) . The detection of Chol epoxide in UV-induced skin cancer (9) and cholestane triol in human colon cancer (10) suggests that the etiology of these cancers may be associated with Chol epoxide, which is not xenobiotic but appears to originate in vivo or be assimilated as a food contaminant. Petrakis et al. (11) have recently reported that human breast fluid can contain enormous levels (up to 780 ,M) of Chol epoxide. The origin of this Chol epoxide is unknown although its levels are directly related to breast fluid cholesterol content, which increases progressively with advancing age.
Studies have shown that Chol epoxide induces chromosomal damage, DNA repair (12) , and oncogenic transformation (13, 14) of mammalian cells. Conversely, negative findings were obtained with Chol epoxide in the Ames Salmonella mutagenicity assay (15, 16) , and Chol epoxide did not induce tumors nor promote N-methyl-N'-nitro-N-nitrosoguanidine carcinogenesis in rats and mice (15, 17, 18) , although careful determinations of Chol epoxide uptake and transformation were not made in several of these studies.
Furthermore, the proportions of the Sa,6a isomer and its diastereomer, Chol 5P,6p-epoxide, both of which may be formed enzymatically or by peroxidation (1, 2, 4) were not indicated. Nonabsorption (19) or low levels of uptake and metabolism of Chol epoxide (20) would be expected to affect its genotoxicity, while conversion to cholestane triol could impair lipogenesis (21) , as this compound has been reported to be cytotoxic (14, 22) .
In the present study, we have measured Chol epoxide uptake and apparent metabolism as well as its genotoxicity in parallel experiments with V79 Chinese hamster cells. Using established procedures (23, 24) , we found that Chol epoxide is mutagenic in Chinese hamster V79 cells, and we describe relationships between this mutagenicity and cytotoxicity, inhibition of DNA synthesis, and transformation of Chol epoxide to cholestane triol.
MATERIALS AND METHODS
Chemicals, Radiochemicals, and Cell Culture Supplies. Chol, Chol epoxide, and cholestane triol were purchased from Steraloids (Wilton, NH). Chol epoxide was found to be contaminated with =8% Chol and -2% cholestane triol as determined by thin-layer and gas chromatographic analysis (25) . We therefore used purified Chol epoxide and cholestane triol for all experiments. Both compounds were purified by silicic acid column chromatography using benzene/ethyl acetate (3:2) as the eluting solvent. Alternatively, Chol epoxide and radiolabeled Chol epoxide and cholestane triol were prepared by reaction of [4-1 C] Chol (New England Nuclear), or unlabeled Chol (Sigma), with monoperphthalic acid as described (25) . The purity and characteristics of labeled and unlabeled Chol epoxide were checked by gas chromatography/mass spectrometry using a Hewlett-Packard model 5992 GC/MS fitted with a 6 ft (1.86 m) 3% OV-101 packed column and operated isothermally at 270°C. Further characterization was accomplished by thin-layer radiochromatography (26) (26) .
The sources of N-methyl-N'-nitro-N-nitrosoguanidine and [6-3H] thymidine and of the V79 Chinese hamster lung fibroblasts and the media and plasticware used in their culture have been described (24) . All for intervals of 2-24 hr. The 60-mm and 100-mm dishes contained 5 ml and 10 ml, respectively, of medium, which was aspirated after incubation. The monolayers were then washed twice with complete medium and incubated with fresh complete medium.
Assay of DNA Synthesis, Cytotoxicity, and Mutagenesis. These assay procedures have been characterized (23, 24, 27) . DNA (24) . The frequencies of 8-azaguanine-resistant (zsGr) mutants were determined using an expression time of 6 days with replating as described (24 19.4 ;iCi/Amol) to 60-mm dishes. Final concentrations of these steroids were adjusted up to a maximum of 62 uM by addition of nonradioactive compound in acetone, and dishes were incubated for intervals up to 24 hr. After incubation, the medium was collected and saved, the monolayers were washed twice with fresh medium, and the washings were pooled. The cells were scraped from the dishes and collected by centrifugation at 500 x g for 10 min. The stability of Chol epoxide and cholestane triol in complete medium was examined by incubating the medium alone for similar time intervals. Lipids were extracted as described (25) . Isolation, quantitation, radioactivity measurements of the steroids, and the methods for measuring epoxide hydration were carried out as described (26) . The Fig. 2 . The apparent difference between the cultures studied and described in Figs. 1 and 2 was the batch of serum used in the culture medium. There is uncertainty as to whether serum differences accounted for the disparate behavior of the cells; nevertheless, the results shown in Fig. 2 and reported in Table 3 show clear differences in Chol epoxide conversion to cholestane triol as well as in Chol epoxide toxicity and mutagenesis. The pattern of Chol epoxide uptake by the cells was similar to that shown in Fig. 1 , although the amount accumulated was -30% less over the same time period. Moreover, 26-29% of the Chol epoxide taken up was converted to cholestane triol.
Inhibition of DNA Synthesis. Incorporation of [3H]thymidine into DNA was determined 45 min after treatment of the cells with Chol, Chol epoxide, and cholestane triol, and this incorporation protocol is considered to be a measure of the effects of Chol, Chol epoxide, and cholestane triol on DNA synthesis (23, 27) . Twenty-four-hour treatment with _11.9 ,uM cholestane triol produced a significant inhibition of [3H]thymidine incorporation into DNA (Table 1) ; however, at this concentration 2-to 4-hr treatment had no effect on DNA synthesis. Twenty-four-hour treatment with _24.8 ,uM
Chol epoxide produced a significant inhibition of DNA synthesis. Maximal inhibition was found at 62 ,uM (the highest concentration studied) and was significant only after 16 hr of treatment. In this regard, Chol epoxide was found to be less potent than cholestane triol in inhibiting DNA synthesis. Cytotoxicity. Chol (25 uM) was not cytotoxic. The effects of Chol epoxide and cholestane triol on the survival of V79 cells are shown in Fig. 3 . The surviving fraction of V79 cells decreased exponentially on treatment of the cells for 24 hr with Chol epoxide and cholestane triol. Using these data, the dose that produces a decrease in the surviving fraction equal to l/e in the linear region of the survival curve of Chol epoxide and cholestane triol was calculated to be 106 ± 15 juM and 43 ± 4 uM, respectively, indicating that cholestane triol was more than twice as toxic as Chol epoxide. The surviving Mutagenesis. The z8Gr mutants produced by the protocol used for these measurements of mutagenesis have been thoroughly characterized and shown to be hypoxanthine/guanine phosphoribosyltransferase-deficient mutants (24) . In the present experiments, the spontaneous mutation frequency was 0.5 ± 0.24 mutants per 105 survivors (nine experiments). The mutation frequencies of cultures treated with Chol were not significantly different from the spontaneous mutation frequency.
The mutation frequencies produced by treating cultures with Chol epoxide and cholestane triol are given in Table 2 .
Treatment of V79 cells for 2-24 hr with 62 AM Chol epoxide produced mutants at frequencies that were reproducibly 4.6-to 11.8-fold greater than the spontaneous mutation frequencies. Although the mutation frequency was not dose dependent nor time dependent over the entire range of doses and treatment times, significantly fewer mutants were produced produced mutation frequencies that were significantly higher than the background mutation frequency, but a higher concentration of cholestane triol, which caused the cells to detach from the dishes, and lower concentrations of cholestane triol did not produce mutation frequencies significantly greater than the background mutagenesis.
Comparison with the mutation frequencies produced by 6.8 MM N-methyl-N'-nitro-N-nitrosoguanidine (2-hr treatment) indicates that Chol epoxide was weakly mutagenic and that at less than 17.8 AM cholestane triol was not significantly mutagenic.
Relationships Between Cytotoxicity, Mutagenesis, and Chol Epoxide Hydration. The results given in Tables 1 and 2 and shown in Fig. 3 were obtained with cultures in which the uptake of Chol epoxide was relatively high and its conversion to cholestane triol was relatively low. These results are compared in Table 3 with data from cells that were cultured in medium containing a different batch of serum. These cultures displayed a lower (-=30%) uptake of Chol epoxide and higher (-2-fold) conversion of Chol epoxide to cholestane triol (Fig. 2) . In the latter cells, the Chol epoxide was twice as toxic as in the former cultures and was not significantly mutagenic. These observations show that the cytotoxicity of Chol epoxide can be enhanced and its mutagenicity can be abolished under conditions in which Chol epoxide is efficiently converted to cholestane triol.
DISCUSSION
We have shown that Chol epoxide is a weak mutagen in Chinese hamster V79 cells (Table 2 ), but the conversion of Chol epoxide to cholestane triol appears to modify the mutagenicity of Chol epoxide. Cholestane triol is more toxic (Fig. 3 and  ref. 14) and a more potent inhibitor of DNA synthesis (Table  1) than Chol epoxide, and cytotoxicity was observed after short exposures to cholestane triol, whereas longer exposures were necessary for the marginal mutagenesis induced by 17.8 AM cholestane triol. By contrast, lower concentrations of Chol epoxide and relatively short treatments with Chol epoxide were significantly mutagenic ( Table 2) .
These data suggest that the mutagenicity of Chol epoxide can be decreased by its conversion to cholestane triol, which is more toxic and less mutagenic than Chol epoxide. Table 3 shows that, in cells in which the conversion of Chol epoxide to cholestane triol is enhanced, the cytotoxicity of Chol epoxide was also enhanced and the mutagenicity of Chol epoxide was abolished. The cause of the enhancement of Chol epoxide conversion to cholestane triol in these cells may be related to the batch of serum used in these experiments and is being investigated. Nevertheless, our data indicate that the mutagenicity of Chol epoxide in Chinese hamster V79 cells depends on the capacity of the cells to metabolize Chol epoxide to cholestane triol and can be related to their epoxide hydrolase activities. We attribute our data, showing a plateau in the dose-response for mutagenesis with >12.4 ,uM Chol epoxide, to a selective enhancement of cytotoxicity resulting from an accumulation of cholestane triol. Conflicting data in the literature regarding the genotoxicity of Chol epoxide (12-14, 16-18, 29-31 ) may be the result of dif-ferences in the above enzymatic conversion of Chol epoxide to cholestane triol by the various systems studied. The contribution to Chol epoxide genotoxicity by minor contaminants also remains as a possibility. Painter and Howard (31) reported that inhibition of HeLa cell DNA synthesis was no longer evident when a more highly purified compound was tested. It is assumed that only the a-isomer of Chol epoxide was studied, however, the purified compound may have contained less cholestane triol and a different proportion of the P-3isomer of Chol epoxide, which can be effectively separated from the a-isomer of HPLC. This was not the case in the present study as the same batch of Chol epoxide was used in all experiments. Nevertheless, there is the possibility of differential genotoxicity between the a-and P-isomers of Chol epoxide: our preliminary experiments suggest that the p-isomer is about 5 times more mutagenic than the a-isomer while being approximately as cytotoxic as cholestane triol.
The content of Chol epoxide (total amount of a-and pisomers) measured in rat lung tissue has been reported to be 10-15 AsM (25) . This range is computed from the quantities extracted from freshly excised lung parenchyma and expressed on the basis of tissue water content. Consequently, rat lung tissue, which also displays low Chol epoxide hydrolase activities (26) 
